Sanford Sioux Falls Seeks Input On Blood Loss Clinical Trial 
Alex Strauss Alex Strauss

Sanford Sioux Falls Seeks Input On Blood Loss Clinical Trial 

Bleeding out is the most common cause of preventable death after injury. Researchers at Sanford Health are asking for community input on whether they should participate in an international study. The study will see if a blood clotting drug, given soon after arrival in the emergency department, can improve survival.

Read More
Sanford Researchers Try to Answer Critical Stem Cell Question
Alex Strauss Alex Strauss

Sanford Researchers Try to Answer Critical Stem Cell Question

Researchers at Sanford have embarked on what may be one of the most important stem cell trials ever conducted. This time, they are trying to answer the question of which stem cell source - adipose, bone marrow, or umbilical cord - is most effective for the treatment of knee osteoarthritis.

Read More
Lung Cancer Trial Opened Door for New Research Opportunities
Alex Strauss Alex Strauss

Lung Cancer Trial Opened Door for New Research Opportunities

The recently completed trial on the immunotherapy drug pembrolizumab (Keytruda) at Sanford Health had important implications for non-small cell lung cancer patients in the region. Thanks to Sanford’s involvement, patients with an illness that is often fatal within a year, had access to a promising new treatment long before they might otherwise have even heard about it.

Read More
Sanford Diabetes Trial Reaches Full Enrollment
Alex Strauss Alex Strauss

Sanford Diabetes Trial Reaches Full Enrollment

In February, The Sanford Project: T-Rex Study, a Phase 2 clinical trial on diabetes in children, enrolled the last of its 110 trial participants. The project is studying the potential of a cell therapy developed by Caladrius that uses each patient’s own regulatory T cells, or Tregs, to fight type 1 diabetes.

Read More